Shares of Centene (NYSE:CNC) lost ~10% in the early premarket trading on Friday after the Medicaid-driven managed care firm ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Centene reported a $253 million loss in its second quarter as the provider of government-subsidized health benefits struggles ...

Centene Corp (CNC) reports a mixed quarter with revenue growth but faces earnings pressure, while outlining strategic plans for margin recovery and future profitability.

The market expects Centene (CNC) to deliver a year-over-year decline in earnings on higher revenues when it reports results ...

Centene stock tumbled after reporting a surprise Q2 loss, driven by rising medical costs and a weak outlook, shaking ...

Evaluate the expected performance of Centene (CNC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for ...

Centene Corporation ( NYSE: CNC) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET a - Corporate Participant v - Corporate Participant Andrew Lynn Asher - Chief Financial Officer Jennifer ...

Discover Centene Corporation's Q2 2025 earnings analysis, uncovering setbacks, repricing strategies, and plans for profitability restoration.

Centene's latest analysis results in a reduction to its previous full-year net risk adjustment revenue transfer expectation of about $1.8 billion, which corresponds to a drop in earnings.

Analysts are estimating that Molina Healthcare will report an earnings per share (EPS) of $5.92. Investors in Molina ...

Elevance Health's medical loss ratio was 88.9% in the second quarter, up from 86.4% in the first quarter, reflecting expected ...